Octanate (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate, is a blood coagulation factor presented as a sterile solution for intravenous use. It replaces deficient factor VIII in patients with hemophilia A, helping to control bleeding episodes. GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Octanate is a recombinant factor VIII product that acts within the coagulation cascade to manage bleeding disorders.

- Hemophilia A (severe): Provides factor VIII replacement to prevent and control spontaneous bleeding. - Hemophilia A (moderate): Supports routine prophylaxis to reduce frequency of bleeds. - Hemophilia A (mild) with surgery: Supplies peri‑operative factor VIII to maintain hemostasis during surgical procedures. - Acquired hemophilia A – Provides the necessary factor VIII to counter the auto‑immune inhibition of factor VIII. - C  ​                             ​     ​  …  …  … 

The          …   …  …  …  ...

...